SCHEMBL3796110

SCHEMBL3796110

CSc1c(Cl)cccc1C=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.45
MEN1 O00255 4/20 0.45
KMT2A Q03164 4/20 0.45
TDP1 Q9NUW8 3/20 0.45
LMNA P02545 1/20 0.41
THRB P10828 1/20 0.41
BLM P54132 1/20 0.41
ERN1 O75460 4/20 0.41
CYP1A1 P04798 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP1B1 Q16678 1/20 0.40
TSHR P16473 1/20 0.39
TERT O14746 1/20 0.38
TLR2 O60603 1/20 0.35
TLR1 Q15399 1/20 0.35
TLR6 Q9Y2C9 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
TRIM24 O15164 1/20 0.34
TRIM33 Q9UPN9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8757092 0.79 ALDH1A1 (0.41) ALDH1A1MEN1KMT2ATDP1LMNA
SCHEMBL30862079 0.79 ALDH1A1 (0.41) ALDH1A1MEN1KMT2ATDP1LMNA
SCHEMBL5594805 0.78 CYP1A2 (0.43) ALDH1A1MEN1KMT2ATDP1LMNA
SCHEMBL7757773 0.78 ALDH1A1 (0.56) ALDH1A1MEN1KMT2ATDP1LMNA
SCHEMBL29951357 0.76 ERN1 (0.55) ALDH1A1MEN1KMT2ATDP1LMNA
SCHEMBL28669144 0.75 ALDH1A1 (0.42) ALDH1A1MEN1KMT2ATDP1LMNA
SCHEMBL3409591 0.72 ALDH1A1 (0.50) ALDH1A1MEN1KMT2ATDP1LMNA
SCHEMBL29952946 0.72 ALDH1A1 (0.50) ALDH1A1MEN1KMT2ATDP1LMNA
SCHEMBL8057946 0.72 LMNA (0.42) ALDH1A1MEN1KMT2ATDP1LMNA
SCHEMBL9760066 0.72 PIM1 (0.39) ALDH1A1MEN1KMT2ATDP1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2121585-B1 NOVEL AMINOGUANIDINES AS MELANOCORTIN RECEPTOR LIGANDS ANAMAR AB (SE) 2014-05-28 EP disclosed
US-8372878-B2 Aminoguanidines as melanocortin receptor ligands ANAMAR AB (SE) 2013-02-12 US disclosed
US-20100056641-A1 Novel Aminoguanidines as Melanocortin Receptor Ligands ACURE PHARMA AB (SE) 2010-03-04 US disclosed
EP-2121585-A1 NOVEL AMINOGUANIDINES AS MELANOCORTIN RECEPTOR LIGANDS. Acure Pharma AB (SE) 2009-11-25 EP disclosed
WO-2008071980-A1 NOVEL AMINOGUANIDINES AS MELANOCORTIN RECEPTOR LIGANDS. ACURE PHARMA AB (SE) 2008-06-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100056641-A1 Novel Aminoguanidines as Melanocortin Receptor Ligands MC1R, MC3R, MC4R ALDH1A1 2475/4885MEN1 1535/4885KMT2A 2487/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.